The in-vitro human models market is projected to grow from USD 2,123.8 million in 2026 to USD 8,443.7 million by 2036, at a CAGR of 14.8%. Organ-on-chip systems will dominate with a 46.0% market share, while drug discovery will lead the applications segment with a 54.0% share.